DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Finn RS, Merle P, Granito A. et al.
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: additional analyses from the phase III RESORCE trial.
J Hepatol 2018;
69 (02) 353-358
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.